Actively Recruiting
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
Led by Portland VA Medical Center · Updated on 2025-06-06
24
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
Sponsors
P
Portland VA Medical Center
Lead Sponsor
O
Oregon Health and Science University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Individuals with depression often describe difficulties with memory, attention, concentration, and overall cognitive functioning, which can persist even after mood episodes get better, and can affect treatment and health outcomes. The primary objective of this pilot clinical trial is to evaluate the feasibility and acceptability of a manualized, 8-week, Compensatory Cognitive Training (CCT) intervention for Veterans who received treatment for MDD in the past year and have persistent cognitive functioning deficits. The investigators will compare Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD) to a robust comparator, Goal-focused Supportive Contact (GSC), to evaluate differences in outcome measures. The investigators hypothesize that Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD) will be feasible and acceptable to participants in a pilot trial of ME-CCT-MDD vs. Goal-focused supportive contact (GSC) for Veterans with recent MDD treatment and persistent cognitive symptoms. This study will also evaluate the preliminary magnitude and direction of symptom change on measures of objective cognitive functioning, psychiatric symptomatology, psychosocial functioning, and quality of life. The investigators hypothesize that CCT will improve objective cognitive functioning, psychiatric outcomes, psychosocial functioning, and quality of life in Veterans with recent MDD-related cognitive functioning deficits. Participants who agree to participate in the study will: 1. Take part in an assessment of their cognition, symptoms, and functioning, which will take approximately 2 hours. The assessment will include an interview about their medical, psychiatric, and cognitive history. It will also include questionnaires about their symptoms and daily functioning as well as neuropsychological tests, which are paper-pencil tests that evaluate aspects of cognition such as memory, attention, and problem-solving skills. 2. Be randomly assigned (like the flip of a coin) to receive Goal-Focused Supportive Contact or Compensatory Cognitive Training. Both treatments will involve weekly groups with a mental health provider for approximately 2 hours per week for 8 weeks. Goal-Focused Treatment includes setting and achieving short-term and long-term goals for improving cognition and functioning. Compensatory Cognitive Training includes training in strategies to improve cognition and manage stress. 3. Complete a follow-up assessment of cognition, symptoms, and functioning 8 weeks after they begin treatment, as well as a brief interview about their experience in the group. These assessment sessions will take approximately 2 hours.
CONDITIONS
Official Title
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Veterans 18 years of age or older
- Self-reported or clinically documented concerns about cognitive functioning deficits
- Diagnosed with Major Depressive Disorder and treated at Portland VA within the past year
- Moderate or greater depressive symptoms with PHQ-9 score of 10 or higher
- Current cognitive deficits shown by performance at least 1 standard deviation below age norms on two or more tests in one cognitive domain (memory, attention/processing speed, language, executive functioning) without memory impairment
You will not qualify if you...
- Unable to understand study risks and benefits
- History of traumatic brain injury as defined by relevant criteria
- Substance use disorder (other than nicotine) in the past 6 months
- Diagnosis of dementia, psychotic disorder, or psychotic features
- Active suicidal intent with significant clinical risk
- Auditory or visual impairments preventing participation in groups or assessments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Portland VA Medical Center
Portland, Oregon, United States, 97239
Actively Recruiting
Research Team
J
Joren Adams
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here